1. Home
  2. CDNA vs IGIC Comparison

CDNA vs IGIC Comparison

Compare CDNA & IGIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • IGIC
  • Stock Information
  • Founded
  • CDNA 1998
  • IGIC 2001
  • Country
  • CDNA United States
  • IGIC Jordan
  • Employees
  • CDNA N/A
  • IGIC N/A
  • Industry
  • CDNA Medical Specialities
  • IGIC Property-Casualty Insurers
  • Sector
  • CDNA Health Care
  • IGIC Finance
  • Exchange
  • CDNA Nasdaq
  • IGIC Nasdaq
  • Market Cap
  • CDNA 1.1B
  • IGIC 1.0B
  • IPO Year
  • CDNA 2014
  • IGIC N/A
  • Fundamental
  • Price
  • CDNA $22.34
  • IGIC $24.21
  • Analyst Decision
  • CDNA Buy
  • IGIC Buy
  • Analyst Count
  • CDNA 8
  • IGIC 3
  • Target Price
  • CDNA $26.43
  • IGIC $23.67
  • AVG Volume (30 Days)
  • CDNA 768.6K
  • IGIC 86.1K
  • Earning Date
  • CDNA 02-26-2025
  • IGIC 02-25-2025
  • Dividend Yield
  • CDNA N/A
  • IGIC 2.38%
  • EPS Growth
  • CDNA N/A
  • IGIC 32.83
  • EPS
  • CDNA N/A
  • IGIC 3.04
  • Revenue
  • CDNA $312,775,000.00
  • IGIC $506,160,000.00
  • Revenue This Year
  • CDNA $19.85
  • IGIC N/A
  • Revenue Next Year
  • CDNA $11.34
  • IGIC $6.64
  • P/E Ratio
  • CDNA N/A
  • IGIC $7.96
  • Revenue Growth
  • CDNA 5.26
  • IGIC 10.67
  • 52 Week Low
  • CDNA $7.42
  • IGIC $11.51
  • 52 Week High
  • CDNA $34.84
  • IGIC $27.00
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 48.07
  • IGIC 50.99
  • Support Level
  • CDNA $22.06
  • IGIC $23.76
  • Resistance Level
  • CDNA $23.56
  • IGIC $24.59
  • Average True Range (ATR)
  • CDNA 1.79
  • IGIC 0.63
  • MACD
  • CDNA 0.07
  • IGIC 0.03
  • Stochastic Oscillator
  • CDNA 25.72
  • IGIC 66.67

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

About IGIC International General Insurance Holdings Ltd.

International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.

Share on Social Networks: